BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharfstein ST. Non-protein biologic therapeutics. Curr Opin Biotechnol 2018;53:65-75. [PMID: 29289799 DOI: 10.1016/j.copbio.2017.12.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bauer EB. Transition metal catalyzed glycosylation reactions – an overview. Org Biomol Chem 2020;18:9160-80. [DOI: 10.1039/d0ob01782e] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Torres-Vanegas JD, Cruz JC, Reyes LH. Delivery Systems for Nucleic Acids and Proteins: Barriers, Cell Capture Pathways and Nanocarriers. Pharmaceutics 2021;13:428. [PMID: 33809969 DOI: 10.3390/pharmaceutics13030428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Boutin JA, Tartar AL, van Dorsselaer A, Vaudry H. General lack of structural characterization of chemically synthesized long peptides. Protein Sci 2019;28:857-67. [PMID: 30851143 DOI: 10.1002/pro.3601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Weng Y, Huang Q, Li C, Yang Y, Wang X, Yu J, Huang Y, Liang XJ. Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology. Mol Ther Nucleic Acids 2020;19:581-601. [PMID: 31927331 DOI: 10.1016/j.omtn.2019.12.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
5 Ambrosio E, Podmore A, Gomes dos Santos AL, Magarkar A, Bunker A, Caliceti P, Mastrotto F, van der Walle CF, Salmaso S. Control of Peptide Aggregation and Fibrillation by Physical PEGylation. Biomacromolecules 2018;19:3958-69. [DOI: 10.1021/acs.biomac.8b00887] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
6 Zhang Y, Davis DA, AboulFotouh K, Wang J, Williams D, Bhambhani A, Zakrewsky M, Maniruzzaman M, Cui Z, Williams RO 3rd. Novel formulations and drug delivery systems to administer biological solids. Adv Drug Deliv Rev 2021;172:183-210. [PMID: 33705873 DOI: 10.1016/j.addr.2021.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
7 Evans BC, Fletcher RB, Kilchrist KV, Dailing EA, Mukalel AJ, Colazo JM, Oliver M, Cheung-Flynn J, Brophy CM, Tierney JW, Isenberg JS, Hankenson KD, Ghimire K, Lander C, Gersbach CA, Duvall CL. An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticles. Nat Commun 2019;10:5012. [PMID: 31676764 DOI: 10.1038/s41467-019-12906-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
8 Guo X, Lou J, Wang F, Fan D, Qin Z. Recent Advances in Nano-Therapeutic Strategies for Osteoarthritis. Front Pharmacol 2022;13:924387. [DOI: 10.3389/fphar.2022.924387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cao Z, Lin S, Liu J. Bacteria-Based Microdevices for the Oral Delivery of Macromolecules. Pharmaceutics 2021;13:1610. [PMID: 34683903 DOI: 10.3390/pharmaceutics13101610] [Reference Citation Analysis]
10 Ahmadi S, Rabiee N, Rabiee M. Application of Aptamer-based Hybrid Molecules in Early Diagnosis and Treatment of Diabetes Mellitus: From the Concepts Towards the Future. Curr Diabetes Rev 2019;15:309-13. [PMID: 29875005 DOI: 10.2174/1573399814666180607075550] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
11 Liu Y, Liu Z, Cui W, Li Y, Qin X, Zhang M, Lin Y. Tetrahedral framework nucleic acids as an advanced drug delivery system for oligonucleotide drugs. APL Materials 2020;8:100701. [DOI: 10.1063/5.0025211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Yang J, Luo Y, Shibu MA, Toth I, Skwarczynskia M. Cell-penetrating Peptides: Efficient Vectors for Vaccine Delivery. Curr Drug Deliv 2019;16:430-43. [PMID: 30760185 DOI: 10.2174/1567201816666190123120915] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]